EdiGene
ID: 5331989A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
9
Funding Rounds
$262.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| We* We****** | - | - | - |
Funding series
Funding Series Analysis
The company EdiGene has raised a total of $15m in funding over 9 rounds.
Key Insights:
- EdiGene Series B round, April 2019: $15m
- EdiGene Series A round, February 2019: $10m
- EdiGene Series A round, August 2018: $14.5m
- EdiGene Series A round, December 2017: $15m
- EdiGene Series B round, April 2021: $61m
- EdiGene Inc Series B round October 2020: $67m
- EdiGene Series B round, October 2020: $67m
- EdiGene Series A round, September 2019: $12.5m
Industries
EdiGene is active in the following industries: